NCT05892263

Brief Summary

After esophagectomy and reconstruction, intestinal ischemia or intestinal paralysis, lack of intestinal stimulation and oral nutrition can aggravate atrophy and impair the permeability of intestinal mucosa, which not only makes it easy for intestinal bacteria and endotoxin to migrate and enter the blood, At present, early intestinal feeding has been proved to protect the integrity of the intestinal mucosa and improve the postoperative systemic inflammatory response and infection rate of patients, especially pneumonia. Relying on parenteral nutrition, coupled with postoperative exhaust gas or defecation with drugs, can be force-fed. In addition to the side effects of gastrointestinal discomfort (nausea, diarrhea, abdominal pain), parenteral nutrition is likely to cause blood sugar instability and liver index. Abnormal and even increased infection rate, gastrointestinal force feeding was delayed for 36-48 hours before starting. At present, there is no research on the effect of early force-feeding on gastrointestinal motility. Therefore, this study aims to explore whether early gastrointestinal force-feeding can not only reduce the infection rate and systemic inflammation, but also promote gastrointestinal motility. Without using drugs, Reduce drug side effects and abdominal discomfort, advance the time of gastrointestinal force-feeding, reduce complications of postoperative lung and wound anastomosis leakage, complete postoperative care for esophageal cancer, and reduce postoperative mortality. At present, there is no research on the effect of early force-feeding on gastrointestinal motility. Therefore, this study aims to explore whether early gastrointestinal force-feeding can not only reduce the infection rate and systemic inflammation, but also promote gastrointestinal motility. Without using drugs, Reduce drug side effects and abdominal discomfort, advance the time of gastrointestinal force-feeding, reduce complications of postoperative lung and wound anastomosis leakage, complete postoperative care for esophageal cancer, and reduce postoperative mortality.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 6, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2022

Completed
7 months until next milestone

First Posted

Study publicly available on registry

June 7, 2023

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 8, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 8, 2025

Completed
Last Updated

June 7, 2023

Status Verified

July 1, 2022

Enrollment Period

2.7 years

First QC Date

September 6, 2022

Last Update Submit

June 6, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • gastrointestinal emptying time

    Start timing the first bowel movement or exhaust time after surgery

    up to 24 hours (time of the first bowel movement or exhaust after surgery )

Study Arms (3)

Early intestinal force-feeding and drugs to promote gastrointestinal motility

EXPERIMENTAL
Other: early feeding

early enteral feeding

EXPERIMENTAL
Other: early feeding

giving force-feeding after gas or defecation

NO INTERVENTION

Interventions

Enteral force feeding with 5% dextrose injection within 24 hours after operation

Early intestinal force-feeding and drugs to promote gastrointestinal motilityearly enteral feeding

Eligibility Criteria

Age20 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Esophagectomy
  • Esophagectomy & reconstruction
  • Esophagotomy
  • Esophageal reconstruction-with gastric tube
  • Esophageal reconstruction-with colon
  • Esophageal reconstruction with small intestine

You may not qualify if:

  • Gastrointestinal perforation
  • Postoperative hemorrhage
  • Intestinal obstruction
  • Shock

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, 100, Taiwan

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 6, 2022

First Posted

June 7, 2023

Study Start

November 1, 2022

Primary Completion

July 8, 2025

Study Completion

July 8, 2025

Last Updated

June 7, 2023

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

Locations